Gene Therapy: a new strategy for the treatment of diseases
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/126046 |
Resumo: | Gene therapy is based on the simple concept that a genetic disease can be corrected by replacing the defective gene. Early trials encountered unforeseen complications and much of the initial enthusiasm dismayed. This paper is a review about different kinds of vectors, their advantages and disadvantages. Strategies for different target tissues is also discussed. Special interest is on strategies for the treatment of cancer, since nowadays this is the area of most clinical trials. The reason is that cancer treatment proved less complex than treatment of monogenic life-treating disorders. |
id |
UFRGS-20_db2a96d04fa4d4365e35ae25bb6fc2ea |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/126046 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
Gene Therapy: a new strategy for the treatment of diseasesTerapia gênica: uma nova estratégia para o tratamento de doençasTerapia gênicavetores viraisvetores não viraiscâncerGene therapyviral vectorsnon-viral vectorscancerGene therapy is based on the simple concept that a genetic disease can be corrected by replacing the defective gene. Early trials encountered unforeseen complications and much of the initial enthusiasm dismayed. This paper is a review about different kinds of vectors, their advantages and disadvantages. Strategies for different target tissues is also discussed. Special interest is on strategies for the treatment of cancer, since nowadays this is the area of most clinical trials. The reason is that cancer treatment proved less complex than treatment of monogenic life-treating disorders.A terapia gênica está baseada no conceito de que uma doença genética pode ser corrigida pela substituição ou adição do gene defeituoso. Muita expectativa foi gerada pelos primeiros protocolos, mas o surgimento de complicações inesperadas levou a uma diminuição do entusiasmo inicial. Neste artigo, é feita uma revisão dos diferentes tipos de vetores utilizados para terapia gênica, com discussão das suas vantagens e desvantagens. Além disso, as estratégias para alguns dos principais tecidos alvo são discutidas. Especial ênfase é dada às estratégias para o tratamento do câncer, área na qual atualmente se concentram a maioria dos protocolos clínicos e que apresenta dificuldades menores do que as envolvidas no tratamento de doenças monogênicas.HCPA/FAMED/UFRGS2022-07-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed Article"A Convite dos Editoresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/126046Clinical & Biomedical Research; Vol. 21 No. 3 (2001): Revista HCPAClinical and Biomedical Research; v. 21 n. 3 (2001): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/126046/85605http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessD. da Silva, Cláudia Silveira Matte, Úrsula Giugliani, Roberto 2022-07-22T13:58:14Zoai:seer.ufrgs.br:article/126046Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-07-22T13:58:14Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
Gene Therapy: a new strategy for the treatment of diseases Terapia gênica: uma nova estratégia para o tratamento de doenças |
title |
Gene Therapy: a new strategy for the treatment of diseases |
spellingShingle |
Gene Therapy: a new strategy for the treatment of diseases D. da Silva, Cláudia Terapia gênica vetores virais vetores não virais câncer Gene therapy viral vectors non-viral vectors cancer |
title_short |
Gene Therapy: a new strategy for the treatment of diseases |
title_full |
Gene Therapy: a new strategy for the treatment of diseases |
title_fullStr |
Gene Therapy: a new strategy for the treatment of diseases |
title_full_unstemmed |
Gene Therapy: a new strategy for the treatment of diseases |
title_sort |
Gene Therapy: a new strategy for the treatment of diseases |
author |
D. da Silva, Cláudia |
author_facet |
D. da Silva, Cláudia Silveira Matte, Úrsula Giugliani, Roberto |
author_role |
author |
author2 |
Silveira Matte, Úrsula Giugliani, Roberto |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
D. da Silva, Cláudia Silveira Matte, Úrsula Giugliani, Roberto |
dc.subject.por.fl_str_mv |
Terapia gênica vetores virais vetores não virais câncer Gene therapy viral vectors non-viral vectors cancer |
topic |
Terapia gênica vetores virais vetores não virais câncer Gene therapy viral vectors non-viral vectors cancer |
description |
Gene therapy is based on the simple concept that a genetic disease can be corrected by replacing the defective gene. Early trials encountered unforeseen complications and much of the initial enthusiasm dismayed. This paper is a review about different kinds of vectors, their advantages and disadvantages. Strategies for different target tissues is also discussed. Special interest is on strategies for the treatment of cancer, since nowadays this is the area of most clinical trials. The reason is that cancer treatment proved less complex than treatment of monogenic life-treating disorders. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-07-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article" A Convite dos Editores |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/126046 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/126046 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/126046/85605 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 21 No. 3 (2001): Revista HCPA Clinical and Biomedical Research; v. 21 n. 3 (2001): Revista HCPA 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767057493917696 |